Biotech, Food, Drug

The National Law Review includes articles impacting the biotechnology, food, and drug industries. In the biotechnology realm, we examine many issues with a cross-over in intellectual property, such as licensing and patenting, intellectual property due diligence, litigation and tax. We also feature content on nanotechnology, biosimilars, greenhouse gas (GHG) regulation, biofuels and, biologics. Analysis includes actions by government entities such as the Food and Drug Administration (FDA), Food Safety and Inspection Service (FSIS), and United States Department of Agriculture (USDA). Common issues address by these agencies and in the industry include various food and beverage regulation, drug pricing and rebates, medical devices, country-of-origin labeling, nutrition labeling, and use of medical and recreational marijuana.

Date	Title	Organization
22 Sep	Employees of Meal Subscription Companies may be Required to Obtain Food Handler Cards	Jackson Lewis P.C.
22 Sep	AG’s Opinion – Licensed and Unlicensed Medicines May Fall Within the Same Relevant Product Market	Covington & Burling LLP
22 Sep	EPA OIG Releases Report on EPA’s Management of Pesticide Funds	Bergeson & Campbell, P.C.
22 Sep	Michigan Farmers React to EPA Announcement to Formally Rescind WOTUS Rule	Varnum LLP
22 Sep	USDA: HACCP Reviews Required in Hurricane-Hit Areas	Keller and Heckman LLP
22 Sep	EPA Issues Direct Final SNURs for Carbon Nanotube (Generic) and Nanocarbon (Generic)	Bergeson & Campbell, P.C.
21 Sep	FDA Releases Training Module for Carriers Subject to the Sanitary Transportation Rule	Keller and Heckman LLP
21 Sep	CFDA Submits to WTO the Third Revised Draft Regulation on the Implementation of the Food Safety Law	Keller and Heckman LLP
21 Sep	EC Begins Consultation on Revising Recommendation on Definition of Nanomaterial	Bergeson & Campbell, P.C.
20 Sep	Hurricane Recovery Alert: Food and Agricultural Disaster Relief for Regulated Industry Following Hurricanes Harvey and Irma	Morgan, Lewis & Bockius LLP